Dr. Jaworski coordinates clinical activities for the Poison Control Center to ensure optimal poison information and toxicology support to the community's patients and providers. He also serves as the Poison Control’s liaison to the Pharmacy Department and Medication Safety Officer.
Education and Training
Pharmacy Residency (PGY-1) - Henry Ford Hospital, Detroit, MI
Critical Care Specialty (PGY-2) - West Virginia University Medicine, Morgantown, WV
Doctor of Pharmacy - Wayne State University, Detroit, MI
Titles and Academic Titles
Clinical Program Manager, Poison Control Center
Departments and Services
Hurth KP, Jaworski A, Thomas KB, Kirsch WB, Rudoni MA, Wohlfarth KM. “The re-emergence of ketamine for treatment in critically-ill adults.” Critical Care Medicine. 2020;48(6):899-911.
Zygowiec J, Solomon S, Jaworski A, Gotlib A, Bloome M. “25C NBOMe ingestion.” Clinical Practice and Cases in Emergency Medicine. 2017;1(4):295-7.
Carreno JJ, Jaworski A, Kenney RM, Davis SL. “Comparative incidence of nephrotoxicity by age group among adult patients receiving vancomycin.” Infectious Diseases and Therapy. 2013;2:201-8.
Posters and Presentations
Hofman M, Jaworski A, Trella J, Osterhoudt K. IV acetaminophen overdose: cases in the American Association of Poison Control Centers’ National Poison Data System, 2017 to 2021. Abstract No 38. North American Congress of Clinical Toxicology 2022, San Francisco, CA, September 2022.
McElroy N, Trella J, Jaworski A. Variables impacting follow-up rates for healthcare facility referral at a Poison Control Center. Abstract No 273. North American Congress of Clinical Toxicology 2022, San Francisco, CA, September 2022.
Jaworski A, Longo L, Trella J, Osterhoudt KC. “Pediatric suicide attempts by poisoning: a five-year investigation of poison center data.” Abstract No. 1181653. Pediatric Academic Societies 2022, Denver, CO, April 2022.
Spetz SL, Jaworski A, Rudoni MA, Wohlfarth K. “Impact of hyperchloremia on renal and intensive care unit outcomes in traumatic brain injuries.” Abstract No. 731. Society of Critical Care Medicine Annual Congress, Orlando, FL, February 2020.
Cheng Y, Jaworski A, Rudoni MA, Wohlfarth K. “Clinical safety and efficacy of prolonged intravenous administration of lacosamide.” UAN: 0048-0000-18-107-L01-P. Ohio Pharmacy Residency Conference, Ada, OH, April 2018.
Leadership and Memberships
Memberships in Professional Organizations
American Academy of Clinical Toxicology (AACT)
American Association of Poison Control Centers (AAPCC)
American Society of Health-System Pharmacists (ASHP)
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.